You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycogen Storage Disease Type I

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glycogen Storage Disease Type IB Trial in Shanghai (Empagliflozin)

Recruiting
  • Glycogen Storage Disease Type IB
  • Shanghai, Shanghai, China
    Xinhua Hospital, Shanghai Jiao Tong University School of Medicin
Jul 17, 2023

Glycogen Storage Disease Type I Trial in Durham (Triheptanoin)

Completed
  • Glycogen Storage Disease Type I
  • Durham, North Carolina
    Duke University Medical Center
Dec 14, 2021

Glycogen Storage Disease Type IA Trial in Groningen ([6,6-2H2]glucose)

Completed
  • Glycogen Storage Disease Type IA
  • [6,6-2H2]glucose
  • Groningen, Netherlands
    University of Groningen, UMC Groningen
Feb 10, 2022

Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)

Recruiting
  • Glycogen Storage Disease Type IA
  • DTX401
  • +3 more
  • Orange, California
  • +16 more
Jan 13, 2023

Biomarker for Glycogen Storage Diseases (BioGlycogen)

Active, not recruiting
  • Fructose Metabolism, Inborn Errors
  • +9 more
    • Rostock, Germany
    • +3 more
    May 12, 2021

    Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

    Recruiting
    • Mucopolysaccharidosis I
    • +7 more
    • There is no intervention
    • San Francisco, California
      University of California San Francisco
    Nov 9, 2022

    MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))

    Recruiting
    • MPS I
    • +8 more
    • Aldurazyme (laronidase)
    • San Francisco, California
      University of California
    Apr 21, 2022

    Myozyme® and of Aldurazyme® in Male and Female Participants of

    Recruiting
    • Pompe Disease
    • Mucopolysaccharidosis Type I (MPS I)
      • Italy, Italy
        Investigational site Italy
      May 3, 2022

      Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))

      Not yet recruiting
      • Pompe Disease
      • +7 more
      • Multi-ingredient supplement (PDT-MIS)
      • Placebo (PLA)
      • (no location specified)
      Nov 8, 2023

      Glucose 6 Phosphatase Deficiency Trial in Warsaw (Empagliflozin)

      Not yet recruiting
      • Glucose 6 Phosphatase Deficiency
      • Warsaw, Poland
        The Children's Memorial Health Institute
      Jun 18, 2021

      Biospecimen in Pediatric Patients and Adult Guardians Diagnosed

      Recruiting
      • Glycogen Storage Disease Type IB
      • Specimen Donation
      • Woburn, Massachusetts
        Sanguine BioSciences, Inc.
      Jun 22, 2023

      Long-Term Development of Muscular Dystrophy Outcome Assessments

      Not yet recruiting
      • LGMD1A
      • +33 more
        • Richmond, Virginia
          Virginia Commonwealth University
        Aug 3, 2023

        Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)

        Recruiting
        • Glycogen Storage Disease VI
        • +4 more
        • No intervention
        • Durham, North Carolina
          Duke University
        Jul 27, 2022

        Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage

        Recruiting
        • Glycogen Storage Disease
        • +2 more
        • No intervention
        • Copenhagen, Copenhange, Denmark
          Neuromuscular Research Unit, 8077
        Oct 26, 2022

        Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease Trial in Gainesville, Decatur, Detroit

        Completed
        Has Results
        • Pompe Disease
        • +2 more
        • alglucosidase alfa
        • Gainesville, Florida
        • +2 more
        Jul 29, 2022

        Baby Detect : Genomic Newborn Screening

        Recruiting
        • Congenital Adrenal Hyperplasia
        • +126 more
          • Liege, Wallonia, Belgium
            CRMN, Hôpital La Citadelle
          Jan 24, 2023

          Pompe Disease -Non-invasive Magnetic Resonance Exploratory Pilot

          Not yet recruiting
          • Pompe Disease
          • McArdle Disease
          • Siemens Magnetom 7T Plus
          • Vienna, Austria
            Medical University of Vienna
          Jul 5, 2023

          Hypoglycemia in Glycogen Storage Disease Type III

          Recruiting
          • Glycogen Storage Disease Type III
          • No Intervention
          • Philadelphia, Pennsylvania
          • +1 more
          Jul 22, 2022

          Glycogen Storage Disease Type IV, Adult Polyglucosan Body Disease Trial in Durham (No intervention)

          Recruiting
          • Glycogen Storage Disease Type IV
          • Adult Polyglucosan Body Disease
          • No intervention
          • Durham, North Carolina
            Duke University Medical Center
          May 20, 2022

          Adeno-Associated Virus Antibody Study in Subjects OTC

          Recruiting
          • Ornithine Transcarbamylase Deficiency
          • +2 more
            • Akron, Ohio
            • +2 more
            Jul 22, 2022

            Glycogen Storage Disease Type II, Pompe Disease (Late-onset) Trial in Milan (Inspiratory Muscle Training (IMT), Inspiratory

            Recruiting
            • Glycogen Storage Disease Type II
            • Pompe Disease (Late-onset)
            • Inspiratory Muscle Training (IMT)
            • Inspiratory Muscle Training (IMT) + Air Stacking
            • Milan, Italy
              IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
            Jul 11, 2023

            Glycogen Storage Disease Type III Trial in Worldwide (biological, other, drug)

            Recruiting
            • Glycogen Storage Disease Type III
            • UX053
            • +4 more
            • Orange, California
            • +9 more
            Jul 22, 2022

            Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2 Trial in Worldwide (Neutralizing Antibody to SPK-3006

            Completed
            • Pompe Disease
            • +5 more
            • Neutralizing Antibody to SPK-3006 capsid
            • Phoenix, Arizona
            • +17 more
            Jul 14, 2021

            Glycogen Storage Disease Type I Trial in Porto Alegre (sweet polvilho, Cornstarch)

            Unknown status
            • Glycogen Storage Disease Type I
            • sweet polvilho
            • Cornstarch
            • Porto Alegre, RS, Brazil
              Ida Vanessa D Schwartz
            Feb 14, 2020

            Glycogen Storage Disease Trial in United States (mRNA-3745)

            Recruiting
            • Glycogen Storage Disease
            • Farmington, Connecticut
            • +4 more
            Jun 10, 2022